Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kirk

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
BMJ Open|November 17, 2021
Patient perspectives on integrated healthcare for HIV, hypertension and type 2 diabetes: a scoping reviewSabine Singh, Ole Kirk, Shabbar Jaffar, et al.
HIV Medicine|April 19, 2026
Systematic screening for age-related comorbidities: Health care optimization among persons with HIV in an outpatient settingAnna Katrine Haslund Roed, Anne-Mette Lebech, Sabine Singh, et al.
Central European Journal of Public Health|October 22, 2008
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published resultsDaria Podlekareva, Wendy Bannister, Amanda Mocroft, et al.
Ugeskrift for Laeger|September 28, 2018
[Breast tuberculosis is a rare cause of breast abscess]Gihan Al-Gameel, Marica Skaar, Tove Flitenborg Tvedskov, et al.
International Journal of STD & AIDS|February 22, 2021
Causes and outcomes of hospitalizations among people living with HIV in Georgia's referral institution, 2012-2017Nino Rukhadze, Ole Kirk, Nikoloz Chkhartishvili, et al.
HIV Medicine|November 5, 2025
Prevalence of current substance and hazardous alcohol use among people with HIV and tuberculosis disease and its impact on tuberculosis treatment outcomes: A systematic reviewAnna Juul Christensen, Laura Risbjerg Omann, Jessica Carlsson, et al.
The Journal of Infectious Diseases|July 24, 2020
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir TherapyMarie Helleberg, Carsten Utoft Niemann, Kasper Sommerlund Moestrup, et al.
AIDS (London, England)|September 23, 2003
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosineJan Gerstoft, Ole Kirk, Niels Obel, et al.
Scandinavian Journal of Infectious Diseases|June 12, 2012
Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort studyMagnus G Rasch, Frederik N Engsig, Bo Feldt-Rasmussen, et al.
Antiviral Therapy|February 6, 2004
A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitorsOle Kirk, Jens D Lundgren, Court Pedersen, et al.
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
BMJ Open|November 17, 2021
Patient perspectives on integrated healthcare for HIV, hypertension and type 2 diabetes: a scoping reviewSabine Singh, Ole Kirk, Shabbar Jaffar, et al.
HIV Medicine|April 19, 2026
Systematic screening for age-related comorbidities: Health care optimization among persons with HIV in an outpatient settingAnna Katrine Haslund Roed, Anne-Mette Lebech, Sabine Singh, et al.
Central European Journal of Public Health|October 22, 2008
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published resultsDaria Podlekareva, Wendy Bannister, Amanda Mocroft, et al.
Ugeskrift for Laeger|September 28, 2018
[Breast tuberculosis is a rare cause of breast abscess]Gihan Al-Gameel, Marica Skaar, Tove Flitenborg Tvedskov, et al.
International Journal of STD & AIDS|February 22, 2021
Causes and outcomes of hospitalizations among people living with HIV in Georgia's referral institution, 2012-2017Nino Rukhadze, Ole Kirk, Nikoloz Chkhartishvili, et al.
HIV Medicine|November 5, 2025
Prevalence of current substance and hazardous alcohol use among people with HIV and tuberculosis disease and its impact on tuberculosis treatment outcomes: A systematic reviewAnna Juul Christensen, Laura Risbjerg Omann, Jessica Carlsson, et al.
The Journal of Infectious Diseases|July 24, 2020
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir TherapyMarie Helleberg, Carsten Utoft Niemann, Kasper Sommerlund Moestrup, et al.
AIDS (London, England)|September 23, 2003
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosineJan Gerstoft, Ole Kirk, Niels Obel, et al.
Scandinavian Journal of Infectious Diseases|June 12, 2012
Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort studyMagnus G Rasch, Frederik N Engsig, Bo Feldt-Rasmussen, et al.
Antiviral Therapy|February 6, 2004
A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitorsOle Kirk, Jens D Lundgren, Court Pedersen, et al.
Pageof 18